Flulaval Quadrivalent2017/2018 (ID Biomedical Corporation of Quebec)
Welcome to the PulseAid listing for the Flulaval Quadrivalent drug offered from ID Biomedical Corporation of Quebec. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | ID Biomedical Corporation of Quebec |
NON-PROPRIETARY NAME: | influenza virus vaccine |
SUBSTANCE NAME: | INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | SUSPENSION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-07-07 |
END MARKETING DATE: | 0000-00-00 |
Flulaval Quadrivalent 2017/2018 VACCINE Details:
Item Description | Flulaval Quadrivalent 2017/2018 from ID Biomedical Corporation of Quebec |
LABELER NAME: | ID Biomedical Corporation of Quebec |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15; 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL) |
START MARKETING DATE: | 2017-07-07 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 19515-896_984ad2ee-5274-44b6-a286-ad2095425872 |
PRODUCT NDC: | 19515-896 |
APPLICATION NUMBER: | BLA125163 |
Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED); INFLUENZA Pharmaceutical Manufacturers / Labelers: